I really don't know that much about the company, took a small position at the recommendation of a friend. If the R/S is approved, I don't know that I'll stay with it. If I remember correctly, the approval of a second drug is anticipated, but being held up by the FDA's inability to approve the production facility located outside the U.S. To my way of thinking if that's all that's holding it back, any idea why they've not gone for European approval. That could lead to the higher prices, perhaps a partnership, and I'd hope the FDA would agree to the European approval of the production facilities if it's an approved drug that they've approved the production facility for.
Gary
Recent NBRVF News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:08:06 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM